Radioiodine-131 in the diagnosis and treatment of metastatic well differentiated thyroid cancer
- PMID: 2261912
Radioiodine-131 in the diagnosis and treatment of metastatic well differentiated thyroid cancer
Abstract
131I continues to be one of the safest and most effective methods of diagnosing and treating metastatic well differentiated thyroid cancer. It is not without risk, however, and must be judiciously applied to carefully prepared and selected patients.